Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing’s Sarcoma Family Tumors

PURPOSE: Temsirolimus was combined with cixutumumab, a fully human IgG1 monoclonal antibody directed at the insulin growth factor-1 receptor (IGF-1R). EXPERIMENTAL DESIGN: Patients received cixutumumab, 6 mg/kg IV weekly, and temsirolimus, 25 mg-37.5 mg IV weekly (4-week cycles), with restaging afte...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Naing, Aung, LoRusso, Patricia, Fu, Siqing, Hong, David S., Anderson, Pete, Benjamin, Robert S., Ludwig, Joseph, Chen, Helen X., Doyle, Laurence A., Kurzrock, Razelle
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3875297/
https://ncbi.nlm.nih.gov/pubmed/22465830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-0061
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items